Outpace Bio vs Emulate
Side-by-side comparison of AI visibility scores, market position, and capabilities
Outpace Bio is a clinical-stage biotech using AI-powered protein design and synthetic biology to develop next-generation cell therapies targeting solid tumors; founded by pioneers in CAR-T and protein engineering; raised $109M Series B in 2024;
About
Outpace Bio is a clinical-stage biotechnology company headquartered in Seattle, Washington, founded to address one of the most significant unmet needs in oncology: creating effective cell therapies for solid tumors. While CAR-T cell therapies have transformed treatment of blood cancers, they have largely failed against solid tumors due to the immunosuppressive tumor microenvironment, T-cell exhaustion, and tumor heterogeneity. Outpace Bio applies AI-powered protein design and synthetic biology to engineer novel cellular logic circuits — custom genetic programs embedded in therapeutic T cells — that allow the cells to sense the tumor environment and respond adaptively rather than becoming exhausted or suppressed.
Pioneering organ-on-chip platform installed in 150+ labs including 17 of the top 25 biopharma companies; launched AVA™ high-throughput 96-chip system in 2025 and holds the only FDA ISTAND-accepted DILI Organ-Chip.
About
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the microstructure and function of human organs. Founded in 2013 as a spin-out from the Wyss Institute at Harvard University, Emulate's chips model the liver, intestine, lung, kidney, brain, and other organ systems with a fidelity that animal models and traditional cell culture cannot match. The technology was originally developed to reduce drug development attrition rates caused by poor translation from animal studies to human clinical outcomes.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.